The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?

Abstract

The utility of adjuvant CMF in the treatment of breast cancer has been reanalyzed. The actual percentage of patients who benefit from adjuvant CMF has been shown to be relatively small. The widespread use of adjuvant CMF must be further examined.